Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Klatskin Tumor × Hepatectomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 24 Colorectal Neoplasms 6 Recurrence 5 Liver Neoplasms 4 Cholangiocarcinoma 3 Secondary Malignant Neoplasm of Liver 1 Reperfusion Injury 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Obesity, Morbid 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Metabolic Syndrome 1 Klatskin Tumor 1 Disease Progression 1 Conversion Disorder 1 Colonic Neoplasms 1 Abdominal Injuries 1

Interventions

Capecitabine 6 Gemcitabine 5 Cisplatin 5 Liver Transplantation 4 Radiosurgery 3 Fluorouracil 3 toripalimab 2 Specimen Handling 2 Self Expandable Metallic Stents 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 trisacryl gelatin microspheres 1 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 dehydroftorafur 1 Tegafur 1 Stents 1 Sorafenib 1 Saline Solution 1 S 1 (combination) 1 Radiofrequency Ablation 1 Platinum 1 Photosensitizing Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02232932 2021-11-03

TRANSPHIL

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡